No contiene resumen

No contiene resumen

No description

No contiene resumen

No description

Minimally invasive pancreatic surgery has expanded slowly but steadily. The application of this approach in obese patients and/or with periampullary neoplasms is still controversial because of the high complication rate in this group of patients. We present the case of a 62-year-old male, obese (BMI 35.4 Kg/m2), hypertensive and diabetic, who developed severe anemia (Hb 4.9 g/dl) due to duodenal adenocarcinoma. Imaging staging verified localized disease. The patient underwent Hybrid Pancreatoduodenectomy (laparoscopic resection/open minilaparotomy reconstruction). The operative technique and postoperative course are described. The patient had no major complications (moderate acute pancreatitis), the operative time was 540 minutes, the bleeding volume was 400 ml, he required transfusion of 1 unit of globular package and a stay of 8 days. He had no intercurrences during 90 days after surge...

El trasplante de hígado es la única terapia para la enfermedad hepática en etapa terminal. La cirrosis secundaria a hepatitis autoinmune (AIH) es una indicación en el 4-6% para los trasplantes de adultos. Se realizó un estudio retrospectivo con veinte pacientes para describir los resultados y la recurrencia de la AIH en pacientes con trasplantes de hígado.

Simultaneous pancreas and kidney transplantation is the ideal treatment option for patients with type 1 diabetes mellitus with chronic renal failure. Restoring insulin independence and avoiding the need for dialysis dramatically improves the quality of life. Also, the return of euglycemia accomplishes progression and even regression of late diabetes complications, extending overall survival in these patients. These benefits outweigh surgery and immune suppression risks inherent to transplantation. Globally, since 1966 when the first pancreas transplant in Minnesota (United States) was conducted there have been more than 20 000 pancreas transplants with increasing success thanks to the refinement in surgical techniques and new immune suppression schemes. In the present clinical case we report and describe the completion of the first simultaneous pancreas and kidney transplant in Peru.